The University of Queensland

Anti-Parasitic Drug Discovery in Epigenetics (A-PARADDISE) (EU FP7 grant administered by Inserm) (2014–2017)

Grant type:

Institut national de la santé et de la recherche médicale

Researchers:

• 

  Professor David Fairlie

  NHMRC Leadership Fellow and Group L
  

  Institute for Molecular Bioscience

Funded by:

Institut National de la Sante et de la Recherche Medical (INSERM)